[Can the presence of an RNA-lipoprotein complex in human blood serum give evidence of a cancerous disease?].
The fractional composition of serum lipoproteids in patients with malignant tumours and in noncancerous disorders as well as in healthy donors has been investigated to detect the cancer specificity of the appearance of the additional abnormal RNA-lipoprotein fraction. No distinct correlation is found between the presence of the additional serum lipoprotein fraction and human malignancy.